Adam Laing

Company: IMU Biosciences

Job title: Co-Founder & Chief Executive Officer

Seminars:

Precision Immunology and AI approaches for Donor Selection, Product Characterization and Patient Monitoring in Cell Therapy 2:45 pm

Super high resolution, scalable, cellular immune profiling  Systems immunology and AI for optimal donor selection Characterization of cellular pharmacodynamics and host immune dynamics during treatmentRead more

day: Conference Day One - Track A - Afternoon